BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20712522)

  • 1. Cancer pharmacogenomics: do cancer cell lines have the right stuff?
    Auman JT
    Pharmacogenomics; 2010 Aug; 11(8):1035-7. PubMed ID: 20712522
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional profiling in cancer: the path to clinical pharmacogenomics.
    Slonim DK
    Pharmacogenomics; 2001 May; 2(2):123-36. PubMed ID: 11368751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy.
    Efferth T; Miyachi H; Bartsch H
    Cancer Genomics Proteomics; 2007; 4(2):81-91. PubMed ID: 17804870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives and challenges of clinical pharmacogenomics in cancer.
    Pusztai L
    Pharmacogenomics; 2004 Jul; 5(5):451-4. PubMed ID: 15212580
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics technique predicts chemotherapy success.
    Traynor K
    Am J Health Syst Pharm; 2006 Dec; 63(23):2304-6. PubMed ID: 17105999
    [No Abstract]   [Full Text] [Related]  

  • 6. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.
    Auman JT; McLeod HL
    Drug Metab Rev; 2008; 40(2):303-15. PubMed ID: 18464047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacogenetics and pharmacogenomics of cancers].
    Robert J
    Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics: from bedside to clinical practice.
    Marsh S; McLeod HL
    Hum Mol Genet; 2006 Apr; 15 Spec No 1():R89-93. PubMed ID: 16651374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression-driven diagnostics and pharmacogenomics in cancer.
    Wang Y
    Curr Opin Mol Ther; 2005 Jun; 7(3):246-50. PubMed ID: 15977422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine in oncology: where have we come from and where are we going?
    André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
    Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine.
    Squassina A; Severino G; Grech G; Fenech A; Borg J; Patrinos GP
    Pharmacogenomics; 2012 Apr; 13(5):525-8. PubMed ID: 22462744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics for the primary care provider: why should we care?
    Teng K
    Cleve Clin J Med; 2011 Apr; 78(4):241-2. PubMed ID: 21460129
    [No Abstract]   [Full Text] [Related]  

  • 19. miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?
    Dreussi E; Biason P; Toffoli G; Cecchin E
    Pharmacogenomics; 2012 Nov; 13(14):1635-50. PubMed ID: 23148639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer drugs find a companion with new diagnostic tests.
    Schubert C
    Nat Med; 2011 Oct; 17(10):1157. PubMed ID: 21988963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.